Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 3Phase 2 2Phase 1 2Phase 4 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 120Lymphoid 68Other hematologic neoplasm 48Breast 4Myeloid 3Gastrointestinal 3Dermatologic 3CNS 3Tumor-Agnostic 2Thoracic 2Other 2Head & Neck 2Genitourinary 2Other solid neoplasm 1

Conditions

Prostatic Neoplasms 2Neoplasm Metastasis 1

Interventions

Docetaxel 191Gemcitabine 148Prednisone 142pembrolizumab 125enzalutamide 119Abiraterone Acetate 108Nivolumab 107Cisplatin 103Magnetic Resonance Spectroscopy 100Radiotherapy 95Sunitinib 94Leuprolide 91Carboplatin 82Specimen Handling 71Androgen Antagonists 63bicalutamide 60Radiosurgery 60Paclitaxel 59Goserelin 59Ipilimumab 57Bevacizumab 57apalutamide 53Sorafenib 53acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 51Everolimus 49cabozantinib 48abiraterone 46atezolizumab 45cabazitaxel 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Calcium Dobesilate × Genitourinary × Clear all
NCT00176293 2015-04-21

Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer

University of Kentucky

Phase 2 Terminated
2 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT01250717 2014-02-04

Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

Dana-Farber Cancer Institute

Phase 2 Completed
28 enrolled 5 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡